Amgen Inc. (BKK:AMGN06)
Thailand · Delayed Price · Currency is THB 2.700
+0.020 (0.75%)
At close: Jan 30, 2026
Amgen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 34,497 | 32,026 | 26,910 | 24,801 | 24,297 | 24,240 |
Other Revenue | 1,474 | 1,398 | 1,280 | 1,522 | 1,682 | 1,184 |
| 35,971 | 33,424 | 28,190 | 26,323 | 25,979 | 25,424 | |
Revenue Growth (YoY) | 10.56% | 18.57% | 7.09% | 1.32% | 2.18% | 8.83% |
Cost of Revenue | 10,773 | 10,458 | 7,795 | 6,376 | 6,454 | 6,159 |
Gross Profit | 25,198 | 22,966 | 20,395 | 19,947 | 19,525 | 19,265 |
Selling, General & Admin | 6,976 | 7,096 | 5,692 | 5,414 | 5,368 | 5,730 |
Research & Development | 6,854 | 5,964 | 4,784 | 4,434 | 4,819 | 4,207 |
Other Operating Expenses | 208 | 230 | 261 | 1 | 187 | - |
Operating Expenses | 14,038 | 13,290 | 10,737 | 9,849 | 10,374 | 9,937 |
Operating Income | 11,160 | 9,676 | 9,658 | 10,098 | 9,151 | 9,328 |
Interest Expense | -3,359 | -3,665 | -4,075 | -1,533 | -1,208 | -998 |
Interest & Investment Income | 510 | 510 | 1,200 | 127 | 11 | - |
Currency Exchange Gain (Loss) | 54 | -75 | 42 | -233 | -245 | 323 |
Other Non Operating Income (Expenses) | 261 | 512 | 1,128 | -180 | 978 | -26 |
EBT Excluding Unusual Items | 8,626 | 6,958 | 7,953 | 8,279 | 8,687 | 8,627 |
Merger & Restructuring Charges | -1,400 | -2,400 | -1,143 | -30 | - | - |
Gain (Loss) on Sale of Investments | 1,843 | -146 | 1,438 | -479 | -474 | -305 |
Gain (Loss) on Sale of Assets | - | - | - | -567 | - | - |
Asset Writedown | -1,071 | - | -783 | - | - | - |
Legal Settlements | - | - | - | - | - | -189 |
Other Unusual Items | 246 | 197 | 390 | 143 | -7 | - |
Pretax Income | 8,244 | 4,609 | 7,855 | 7,346 | 6,701 | 8,133 |
Income Tax Expense | 1,239 | 519 | 1,138 | 794 | 808 | 869 |
Net Income | 7,005 | 4,090 | 6,717 | 6,552 | 5,893 | 7,264 |
Net Income to Common | 7,005 | 4,090 | 6,717 | 6,552 | 5,893 | 7,264 |
Net Income Growth | 65.60% | -39.11% | 2.52% | 11.18% | -18.87% | -7.37% |
Shares Outstanding (Basic) | 538 | 537 | 535 | 538 | 570 | 586 |
Shares Outstanding (Diluted) | 542 | 541 | 538 | 541 | 573 | 590 |
Shares Change (YoY) | 0.28% | 0.56% | -0.56% | -5.58% | -2.88% | -3.12% |
EPS (Basic) | 13.03 | 7.62 | 12.56 | 12.18 | 10.34 | 12.40 |
EPS (Diluted) | 12.93 | 7.56 | 12.49 | 12.11 | 10.28 | 12.31 |
EPS Growth | 65.12% | -39.47% | 3.14% | 17.80% | -16.49% | -4.42% |
Free Cash Flow | 11,539 | 10,394 | 7,359 | 8,785 | 8,381 | 9,889 |
Free Cash Flow Per Share | 21.30 | 19.21 | 13.68 | 16.24 | 14.63 | 16.76 |
Dividend Per Share | 9.390 | 9.000 | 8.520 | 7.760 | 7.040 | 6.400 |
Dividend Growth | 5.74% | 5.63% | 9.79% | 10.23% | 10.00% | 10.35% |
Gross Margin | 70.05% | 68.71% | 72.35% | 75.78% | 75.16% | 75.78% |
Operating Margin | 31.03% | 28.95% | 34.26% | 38.36% | 35.23% | 36.69% |
Profit Margin | 19.47% | 12.24% | 23.83% | 24.89% | 22.68% | 28.57% |
Free Cash Flow Margin | 32.08% | 31.10% | 26.11% | 33.37% | 32.26% | 38.90% |
EBITDA | 16,481 | 15,157 | 13,590 | 13,358 | 12,549 | 12,929 |
EBITDA Margin | 45.82% | 45.35% | 48.21% | 50.75% | 48.30% | 50.85% |
D&A For EBITDA | 5,321 | 5,481 | 3,932 | 3,260 | 3,398 | 3,601 |
EBIT | 11,160 | 9,676 | 9,658 | 10,098 | 9,151 | 9,328 |
EBIT Margin | 31.03% | 28.95% | 34.26% | 38.36% | 35.23% | 36.69% |
Effective Tax Rate | 15.03% | 11.26% | 14.49% | 10.81% | 12.06% | 10.69% |
Revenue as Reported | 35,971 | 33,424 | 28,190 | 26,323 | 25,979 | 25,424 |
Advertising Expenses | - | 987 | 647 | 841 | 843 | 962 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.